Biochemical differentiation of cholinesterases from normal and Alzheimer's disease cortex

Current Alzheimer Research

Volumn 9, Issue 1, 2012, Pages 138-143

  Ciro, Alexis ^a   Park, Joon ^a   Burkhard, Gary ^a   Yan, Nicole ^a   Geula, Changiz ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Acetylcholinesterase; Alzheimer's disease; Butyrylcholinesterase; Cholinesterase

Indexed keywords

ACETYLCHOLINESTERASE; BACITRACIN; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; INDOLEAMINE; SEROTONIN;

AGED; ALZHEIMER DISEASE; ARTICLE; BIOCHEMISTRY; BRAIN CORTEX; CHOLINESTERASE INHIBITION; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; HUMAN; HUMAN TISSUE; PH; PRIORITY JOURNAL;

ACETYLCHOLINESTERASE; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AUTOPSY; BACITRACIN; BUTYRYLCHOLINESTERASE; CASE-CONTROL STUDIES; CEREBRAL CORTEX; DETERGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; OCTOXYNOL; POLYSORBATES; SEROTONIN;

EID: 84863027013     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720512799015127     Document Type: Article

References (39)

1. Geula C, Mesulam M-M. Cholinergic systems in Alzheimer disease. In (Eds: Terry RD, Katzman R, Bick KL and Sisodia SS). Alzheimer Disease. Philadelphia: Lippincott Williams and Wilkins pp. 269-292 (1999).
2. Mufson EJ, Bothwell M, Kordower JH. Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain. Exp Neurol 105:221-232 (1989).
3. Lehericy S, Hirsch EC, Cervera-Pierot P, Hersh LB, Bakchine S, Piette F, et al. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J Comp Neurol 330: 15-31 (1993).
4. Geula C, Mesulam M-M. Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease. Cerebral Cort 6: 165-177 (1996).
5. Geula C, Nagykery N, Nicholas A, Wu CK. Cholinergic neuronal and axonal abnormalities are present early in aging and in Alzheimer disease. J Neuropathol Exp Neurol 67: 3 09-318 (2008).
6. Perry EK, Blessed G, Tomlinson BE, Perry TH, Crow TJ, Cross AJ, et al. Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes. Neurobiol Aging 2: 251-256 (1981).
7. Mesulam M-M, Geula C. Acetylcholinesterase-rich neurons of the human cerebral cortex: cytoarchitectonic and ontogenetic patterns of distribution. J Comp Neurol 306: 193-220 (1991).
8. Giacobini E. Cholinesterase Inhibitors: from Calabar bean to Alzheimer therapy. In (Ed: Giacobini E). Cholinesterases and Cholinesterase Inhibitors. London: Martin Dunitz. pp. 181-226 (2000).
9. Mesulam M, Guillozet A, Shaw P, Quinn B. Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brain. Neurobiol Dis 9: 88-93 (2002).
10. Mesulam MM, Guillozet A, Shaw P, Levey A, Duysen EG, Lockridge O. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 110: 627-639 (2002).
11. Wright CI, Geula C, Mesulam M-M. Neuroglial cholinesterases in the normal brain and in Alzheimer's disease: relationship to plaques, tangles and patterns of selective vulnerability. Ann Neurol 34: 373-384 (1993).
12. Geula C, Mesulam M-M. Cholinesterases and the pathology of Alzheimer's disease. Alz Dis Assoc Disor 9: 23-28 (1995).
13. Geula C, Mesulam M-M. Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease. Brain Res 498: 185-189 (1989).
14. Mesulam M-M, Geula C, Moran MA. Anatomy of cholinesterase inhibition in Alzheimer's disease: effect of physostigmine and tetrahydroaminoacridine on plaques and tangles. Ann Neurol 22: 683-691 (1987).
15. Moran MA, Mufson EJ, Gomez-Ramos P. Cholinesterases colocalize with sites of neurofibrillary degeneration in aged and Alzheimer's brains. Acta Neuropathol (Berl) 87: 284-292 (1994).
16. Moran MA, Mufson EJ, Gomez-Ramos P. Colocalization of cholinesterases with beta amyloid protein in aged and Alzheimer's brains. Acta Neuropathol (Berl) 85: 362-369 (1993).
17. Sani S, Traul D, Klink A, Niaraki N, Gonzalo-Ruiz A, Wu CK, Geula C. Distribution, progression and chemical composition of cortical amyloid-beta deposits in aged rhesus monkeys: similarities to the human. Acta Neuropathol (Berl) 105: 145-156 (2003).
18. Geula C, Nagykery N, Wu CK. Amyloid-beta deposits in the cerebral cortex of the aged common marmoset (Callithrix jacchus): incidence and chemical composition. Acta Neuropathol (Berl) 103: 48-58 (2002).
19. Carson K, Geula C, Mesulam M-M. Electron microscopic localization of cholinesterase activity in Alzheimer brain tissue. Brain Res 540: 204-208 (1991).
20. Wright CI, Geula C, Mesulam M-M. Protease inhibitors and indoleamines selectively inhibit cholinesterases in the histopathologic structures of Alzheimer disease. Proc Natl Acad Sci USA 90: 683-686 (1993).
21. Checler F, Grassi J, Vincent JP. Cholinesterases display genuine arylacylamidase activity but are totally devoid of intrinsic peptidase activities. J Neurochem 62: 756-763 (1994).
22. George ST, Balasubramanian AS. The identity of the serotoninsensitive aryl acylamidase with acetylcholinesterase from human erythrocytes, sheep basal ganglia and electric eel. Eur J Biochem 111: 511-524 (1980).
23. Majumdar R, George ST, Balasubramanian AS. Serotonin-sensitive aryl acylamidase activity of platelet acetylcholinesterase. Biochem Pharmacol 31: 2319-2325 (1982).
24. Lahiri DK, Lewis S, Farlow MR. Tacrine alters the secretion of the beta-amyloid precursor protein in cell lines. J Neurosci Res 37: 777-787 (1994).
25. Greig NH, Utsuki T, Yu Q, Zhu X, Holloway HW, Perry T, Lee B, Ingram DK, Lahiri DK. A new therapeutic target in Alzheimer's disease treatment: attention to butyrylcholinesterase. Curr Med Res Opin 17: 159-165 (2001).
26. Shaw KT, Utsuki T, Rogers J, Yu QS, Sambamurti K, Brossi A, et al. Phenserine regulates translation of beta -amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development. Proc Natl Acad Sci USA 98: 7605-7610 (2001).
27. Inestrosa NC, Alvarez A, Perez CA, Moreno RD, Vicente M, Linker C, et al. Acetylcholinesterase accelerates assembly of amyloidbeta- peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme. Neuron 16: 881-891 (1996).
28. Barber KL, Mesulam M-M, Krafft GA, Klein WL. Butyrylcholinesterase (BChE) alters the aggregation state of Ab amyloid. Soc Neurosc Abst 72: 1172 (1996).
29. Reyes AE, Chacon MA, Dinamarca MC, Cerpa W, Morgan C, Inestrosa NC. Acetylcholinesterase-Abeta complexes are more toxic than Abeta fibrils in rat hippocampus: effect on rat betaamyloid aggregation, laminin expression, reactive astrocytosis, and neuronal cell loss. Am J Pathol 164: 2163-2174 (2004).
30. Mesulam M-M, Geula C. Butyrylcholinesterase reactivity differentiates the amyloid plaques of aging from those of dementia. Ann Neurol 36: 722-727 (1994).
31. Darvesh S, Hopkins DA, Geula C. Neurobiology of butyrylcholinesterase. Nat Rev Neurosci 4: 131-138 (2003).
32. Perry EK, Perry RH, Blessed G, Tomlinson BE. Changes in brain cholinesterases in senile dementia of Alzheimer type. Neuropathol Appl Neurobiol 4: 273-277 (1978).
33. Atack JR, Perry EK, Bonham JR, Candy JM, Perry RH. Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system. J Neurochem 47: 263-277 (1986).
34. Arnold SE, Hyman BT, Flory J, Damasio AR, Van Hoesen GW. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cerebral Cortex 1: 103-116 (1991).
35. Ellman GL, Courtney KV, Andres V, Featherstone RM. A new and rapid colorimetric determination of acetylcholinesterase. Biochem Pharmacol 7: 88-95 (1961).
36. Li B, Stribley JA, Ticu A, Xie W, Schopfer LM, Hammond P, et al. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse. J Neurochem 75: 1320-1331 (2000).
37. Streit WJ, Sammons NW, Kuhns AJ, Sparks DL. Dystrophic microglia in the aging human brain. GLIA 45: 208-212 (2004).
38. Geula C. Pathological diagnosis of Alzheimer's disease. In (Eds: Scinto LFM and Daffner KR). Early Diagnosis of Alzheimer's Disease. Totowa: Humana Press pp. 65-81 (2000).
39. Kalaria RN, Kroon SN, Grahovac I, Perry G. Acetylcholinesterase and its association with heparan sulphate proteoglycans in cortical amyloid deposits of Alzheimer's disease. Neuroscience 51:177-184 (1992).